Twin Capital Management Inc Dexcom Inc Transaction History

Twin Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$80.99 - $107.93 $730,934 - $974,068	-9,025 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$84.79 - $104.74 $100,052 - $123,593	-1,180 Reduced 11.56%	9,025 $3.24 Million
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $29,952 - $40,128	-384 Reduced 3.63%	10,205 $3.77 Million
Q3 2020 Nov 05, 2020	BUY	$95.51 - $112.95 $427,789 - $505,903	4,479 Added 73.31%	10,589 $4.37 Million
Q2 2020 Aug 04, 2020	BUY	$62.68 - $105.34 $382,974 - $643,627	6,110 New	6,110 $2.48 Million

1,123

353M

4.19M

4.54M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $42.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Twin Capital Management Inc with notifications on news.